title: Reticulocytes in haematological disorders.
abstract: The increased precision of flow cytometric techniques permits the recognition of small differences even in the low or normal range of the reticulocyte count. Moreover, measurement of the RNA content of reticulocytes makes possible the identification of the youngest highly fluorescent macroreticulocytes (HFR) prematurely delivered from bone marrow in conditions of increased erythropoietic stimulation. The aim of this study was the definition, using the dedicated flow cytometers Sysmex R-1000 or R-3000 (Toa Medical Electronics Ltd, Kobe, Japan), of reticulocyte absolute number and HFR percentage in patients with haematological disorders prior to any treatment. Analysis of 54 healthy subjects and 100 untreated patients with five types of haematological disease is presented. In haemolytic anaemias (15 cases) both the reticulocyte count and HFR were greatly increased and the reticulocyte count was inversely correlated with Hb level, as in the reference population. In polycythaemia vera (20 cases) reticulocytes were moderately increased and directly correlated with Hb. In dyserythropoietic syndromes (20 cases) reticulocytes were low and HFR moderately increased; HFR showed an inverse correlation with Hb. In acute myeloid leukaemia (30 cases) reticulocytes were low and HFR increased; reticulocytes correlated with both HFR and Hb. In acute lymphoid leukaemia (15 cases), while the reticulocyte count did not differ from the reference group, the HFR was increased. These results provide reference values for the evaluation of reticulocyte counts and HFR in haematological diseases. From a physiopathological standpoint, they suggest that in anaemic patients the reticulocyte count directly reflects effective bone marrow erythrocyte production, while the proportion of circulating HFR more closely reflects the intensity of erythropoietic stimulation.
authors.affiliation: Universita Cattolica, Roma, Italy.
authors.forename: G
authors.initials: G
authors.lastname: d'Onofrio
authors.forename: R
authors.initials: R
authors.lastname: Kuse
authors.forename: C
authors.initials: C
authors.lastname: Foures
authors.forename: J M
authors.initials: JM
authors.lastname: Jou
authors.forename: M
authors.initials: M
authors.lastname: Pradella
authors.forename: G
authors.initials: G
authors.lastname: Zini
mesh_terms: D000328:Adult; D000742:Anemia, Dyserythropoietic, Congenital; D000743:Anemia, Hemolytic / Q000097:blood / Q000175:diagnosis / Q000473:pathology; D005260:Female; D005453:Fluorescence; D006402:Hematologic Diseases / Q000097:blood* / Q000175:diagnosis; D006454:Hemoglobins / Q000737:chemistry; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000175:diagnosis / Q000473:pathology; D007958:Leukocyte Count; D016014:Linear Models; D008297:Male; D011087:Polycythemia Vera / Q000097:blood / Q000175:diagnosis / Q000473:pathology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma; D012016:Reference Values; D017701:Reticulocyte Count / Q000379:methods; D012156:Reticulocytes / Q000737:chemistry / Q000473:pathology*
chemical_list: D006454:Hemoglobins